Growth Hormone and Releasing Factors

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Online Inquiry

CAT# Product Name M.W Molecular Formula Inquiry
G09001 PPT, Prepro Thyrotropin-Releasing Hormone (TRH) (160-169) 1198.3 Inquiry
G09002 GRF (1-29) amide (human) 3357.93 C149H246N44O42S Inquiry
G09003 GRF (1-29) amide (rat) 3473.07 C155H251N49O40S Inquiry
G09004 Growth Hormone Pro-Releasing Factor, human 3568.1 C153H248N44O50S2 Inquiry
G09005 Growth Hormone Releasing Factor, GRF (1 - 40), amide, human 4543.1 Inquiry
G09006 GRF (1-40), human 4544.1 C194H317N61O63S1 Inquiry
G09007 GRF, mouse 5032.9 C220H365N69O64S1 Inquiry
G09008 Growth Hormone Releasing Factor, GRF (1 - 44), amide, human 5039.7 Inquiry
G09009 GRF (free acid) (human) 5040.70 C215H357N71O67S Inquiry
G09010 GRF (porcine) 5108.83 C219H365N73O66S Inquiry
G09011 GRF (ovine, caprine) 5121.86 C221H368N72O66S Inquiry
G09012 Growth Hormone (1-43), human 5216.2 C240H358N62O67S1 Inquiry
G09013 GRF (rat) 5232.89 C225H361N77O66S Inquiry
G09014 Growth Hormone (6-13), human 935.2 C41H66N12O13 Inquiry
G09015 (beta-Asp3)-GRF (human) 5039.72 Inquiry
G09016 (D-Ala2)-GRF (1-29) amide (human) 3357.93 Inquiry
G09017 (Nle27)-GRF (1-29) amide (human) 3339.89 Inquiry
G09020 Acetyl-(Tyr1,D-Arg2)-GRF (1-29) amide (human) 3485.08 Inquiry
G09021 Acetyl-(Tyr1,D-Phe2)-GRF (1-29) amide (human) 3476.06 Inquiry

Introduction

The growth hormone and releasing factors is a tumor-derived peptide, primary structure of which is H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2. The long-awaited hypothalamic growth hormone and releasing factor (GRF) has changed this situation that injections of bovine growth hormone (bGH) increase milk yield in cows and possibly stimulate growth rate in cattle and sheep. The natura peptide is at least 43 amino acids long. There are some common growth hormone and releasing factor: human pancreatic GRF (hpGRF-44, hpGRF-40, hpGRF-29-NH2) and rat hypothalamic GRF (rhGRF-29-NH2).

Mechanism of action

The rat hypothalamic GRF shares a 67% amino acid homology with hpGRF-43 and a 72% homology in the sequence 1-29. This species difference might account for the fact that rhGRF-29- NH2 released significantly less GH in fed sheep when compared with hpGRF-44. The species-specificity argument would be more convincing that hpGRF-40 and hpGRF-29-NH2 stimulated a significantly greater release of GH in sheep than rhGRF-29-NH2. The hpGRF-stimulated GH release is Ca2+ dependent. Besides, the hpGRF in rat anterior pituitary cell cultures was tested, in which increased GH release was stimulated by 10 nM hpGRF-44 as early as 20 rain following addition, reaching a plateau after 3 hr. In another experiment, however, injection of 7 μg hpGRF-44 into Nembutal-anesthetized rats significantly increased somatostatin levels in the hepatic portal plasma 15 min after injection.

Application of Growth Hormone and Releasing Factors

The neuroregulation of GH secretion is mediated at the pituitary by hypothalamic GRF and somatostatin. Human pancreatic GRF (hpGRF-44) has been found to stimulate GH secretion in ruminants. And research shows that the persistency of the GH response to hpGRF-44 is increased by passive immunization against somatostatin in rabbits. Besides, the somatomedin C is known to be raised by hpGRF-40 in man. Furthermore, it has been shown that secretin, gastric inhibitory polypeptide and glucagon, some of which may be raised by feeding, reduce the hpGRF-40-stimulated GH secretion

References

  1. ,Guillemin, R., Brazeau, P., Bohlen, P., Esch, F., Ling, N., & Wehrenberg, W. B. (1982). Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science, 218(4572), 585-587.
  2. Hart, I. C., Chadwick, P. M. E., Coert, A., James, S., & Simmonds, A. D. (1985). Effect of different growth hormone-releasing factors on the concentrations of growth hormone, insulin and metabolites in the plasma of sheep maintained in positive and negative energy balance. Journal of endocrinology, 105(1), 113-119.
  3. Shoji, A., Sugimoto, E., Orita, S., Nozawa, K., Yanagida, A., Shibusawa, Y., & Sugawara, M. (2010). A reusable liposome array and its application to assay of growth-hormone-related peptides. Analytical and bioanalytical chemistry, 397(3), 1377-1381.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 Compstatin is a 13-residue cyclic peptide (Ile1-Cys2-Val3-Val4-Gln5-Asp6-Trp7-Gly8-His9-His10-Arg11-Cys12-Thr13- ...

 Ecallantide, sold under the trade name Kalbitor, is a plasma kallikrein inhibitor, consisting of sixty amino aci ...

 PBP 10 (RhoB-Glu-Arg-Leu-Phe-Glc-Val-Lys-Glc-Arg-Arg) is a 10-aa-long rhodamine-linked and membrane-permeable pe ...

 MEN 10376 (Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Lys-NH2) is an analogue of Neurokinin A (NKA), which has a selective af ...

  Eptifibatide acetate is a white or white-off powder, soluble in water and freely soluble in 1% acetic in water, ...

Quick Inquiry
×
Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.